GI
CRBU icon

GAMMA Investing’s Caribou Biosciences CRBU Stock Holding History

GAMMA Investing’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-262
Closed -$1.35K – 3467
2024
Q1 		$1.35K Buy
262
+195
+291% +$1.2K ﹤0.01% 2871
2023
Q4 		$411 Buy
+67
New +$331 ﹤0.01% 3001

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAMMA Investing's CRBU Position: Q2 2024 in Review

GAMMA Investing sold out of Caribou Biosciences (CRBU) in Q2 2024, closing a stake of 262 shares — an estimated $1.35K sold.

GAMMA Investing first reported a position in CRBU in Q4 2023 and held it in 2 quarters. The position peaked at $1.35K in Q1 2024. 140 funds tracked by Wall St. Rank hold CRBU as of Q2 2024.

  • GAMMA Investing reported no remaining Caribou Biosciences position as of Q2 2024 after selling out during the quarter.
  • GAMMA Investing sold 262 Caribou Biosciences shares in Q2 2024, an estimated $1.35K.
  • GAMMA Investing first reported a position in Caribou Biosciences in Q4 2023 and held it in 2 quarters.
  • GAMMA Investing's Caribou Biosciences position peaked at $1.35K in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2024.

Based on GAMMA Investing's 13F filing for Q2 2024, filed 2 Jul 2024.